Atrial fibrillation (AF) is the most common clinical tachyarrhythmia. In Europe, AF is expected
to reach a prevalence of 18 million by 2060. This estimate will increase hospitalization for AF …

Atrial fibrillation (AF) is the most common sustained arrhythmia and has significant clinical
impact. Over the last decade, our understanding of the genetics of AF has expanded …

Atrial fibrillation (AF) is an arrhythmia with a genetic basis. Over the past decade, rapid
advances in genotyping technology have revolutionised research regarding the genetic …

Atrial fibrillation (AF) is the most common cardiac rhythm disorder and the prevalence is
increasing. The disease confers an increased risk of severe complications such as heart …

Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased
morbidity. As the population ages and the prevalence of AF continues to rise, the …

Atrial fibrillation (AF) has become a growing global epidemic and a financial burden for
society. The past 10 years have seen significant advances in our understanding of the …

Genetic variation is an important determinant of atrial fibrillation (AF) susceptibility.
Numerous rare variants in protein-coding sequences of genes have been associated with …

Currently, atrial fibrillation is the most common sustained arrhythmia in clinical practice. The
pathophysiological mechanisms of atrial fibrillation are complex. A better understanding of …

Atrial fibrillation (AF) is the most common heart rhythm disorder worldwide and may have
serious cardiovascular health consequences. AF is associated with increased risk of stroke …

Atrial fibrillation (AF) is the most common atrial arrhythmia and is subcategorized into
numerous clinical phenotypes. Given its heterogeneity, investigations into the genetic …